OpGen, Inc. ã¯ãç±³åœããã³åœéçã«ååæ
å ±è£œåããã³ãµãŒãã¹ã®éçºã«æºãã粟å¯å»çäŒæ¥ã§ããå瀟ã¯åå蚺æããã³æ
å ±ç§åŠã掻çšããŠææç察çãæ¯æŽããŠããŸãããŸããçåœãè
ããææçã«é¢ããæ
å ±ã§èšåºå»ãæ¯æŽããæ£è
ã®è»¢åž°ãæ¹åããå€å€èæ§åŸ®çç©ã«ããææçã®æ¡å€§ãæžãããŠããŸããå瀟ã®è£œåã«ã¯ãããããæ€äœããåé¢ããã现èã³ãããŒããããŸããŸãªçŽ°èæ žé
žããã³æèè¬èæ§ (AMR) ã®éºäŒç決å®å åãæ€åºããã³èå¥ããããã®äœå€èšºæãã¹ãã§ãã Acuitas AMR Gene PanelãããŸããŸãªæææ§ç
åäœãèå¥ããããã® QuickFISH ããã³ PNA FISH 蚺æãã¹ã補åãããã³ SARS CoV-2 ãã¹ããããããããŸããããã«ãå瀟ã¯ã¯ã©ãŠãããŒã¹ã® HIPAA æºæ æ
å ±ç§åŠã§ãã Acuitas Lighthouse æ
å ±ç§åŠã·ã¹ãã ãæäŸããŠãããèšåºæ€æ»çµæãšæ£è
ããã³ç
颿
å ±ãçµã¿åãããŠãç
é¢ããã³æ£è
ã±ã¢ç°å¢ã§ MDRO ã管çã§ããããã«åæãšæŽå¯ãæäŸããŸãã Unyvero ãã©ãããã©ãŒã ã¯ãèªååããããµã³ãã«æºåãåæãããã³çŸæ£é¢é£ç
åäœãšæçç©è³ªèæ§ããŒã«ãŒã®èå¥ãçµ±åãããèªååããããµã³ãã«ããåçãŸã§ã®åå蚺æãã©ãããã©ãŒã ã§ãããŸããARES ãã¯ãããžãŒ ãã©ãããã©ãŒã ã«ã¯ã次äžä»£ã·ãŒã±ã³ã·ã³ã° ããŒã¹ã§äººå·¥ç¥èœã掻çšããã¯ã©ãŠãããŒã¹ã®ãã€ãªã€ã³ãã©ããã£ã¯ã¹ ãœãªã¥ãŒã·ã§ã³ãæäŸã㊠AMR ãããã¡ã€ã«ãçæããæèè¬æåæ§ãã¹ãã®çµæãäºæž¬ãã ARESdb ãå«ãŸããŠããŸããOpGen, Inc. ã¯ããã¥ãŒãšãŒã¯å·ä¿å¥å±ãšæŠç¥çã«ååããŠãå»çæ©é¢ã§æèè¬èæ§ææçãæ€åºã远跡ã管çãããœãªã¥ãŒã·ã§ã³ãéçºããŠããŸããå瀟㯠2001 幎ã«èšç«ãããã¡ãªãŒã©ã³ãå·ããã¯ãã«ã«æ ç¹ã眮ããŠããŸãã